Sterling Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.96M Buy
53,736
+16,018
+42% +$1.78M 0.08% 159
2025
Q1
$4.23M Sell
37,718
-9,946
-21% -$1.11M 0.07% 200
2024
Q4
$4.4M Buy
47,664
+42,040
+748% +$3.88M 0.06% 243
2024
Q3
$472K Buy
+5,624
New +$472K 0.01% 894
2019
Q3
$72.2M Buy
1,138,834
+77,360
+7% +$4.9M 0.68% 45
2019
Q2
$71.7M Buy
1,061,474
+625
+0.1% +$42.2K 0.69% 53
2019
Q1
$69M Buy
1,060,849
+36,675
+4% +$2.38M 0.68% 48
2018
Q4
$64.1M Sell
1,024,174
-63,719
-6% -$3.99M 0.7% 49
2018
Q3
$84M Sell
1,087,893
-17,085
-2% -$1.32M 0.76% 42
2018
Q2
$78.3M Sell
1,104,978
-110,035
-9% -$7.79M 0.73% 49
2018
Q1
$91.6M Buy
1,215,013
+17,233
+1% +$1.3M 0.86% 28
2017
Q4
$85.8M Sell
1,197,780
-21,991
-2% -$1.58M 0.78% 40
2017
Q3
$98.8M Buy
1,219,771
+56,020
+5% +$4.54M 0.93% 25
2017
Q2
$82.4M Buy
1,163,751
+15,144
+1% +$1.07M 0.79% 39
2017
Q1
$78M Buy
1,148,607
+85,179
+8% +$5.79M 0.73% 40
2016
Q4
$76.2M Sell
1,063,428
-42,978
-4% -$3.08M 0.69% 50
2016
Q3
$87.5M Buy
1,106,406
+155,955
+16% +$12.3M 0.81% 44
2016
Q2
$79.3M Buy
950,451
+426,623
+81% +$35.6M 0.72% 48
2016
Q1
$48.1M Buy
523,828
+439,723
+523% +$40.4M 0.44% 83
2015
Q4
$8.51M Buy
84,105
+3,914
+5% +$396K 0.08% 185
2015
Q3
$7.87M Buy
80,191
+11,991
+18% +$1.18M 0.07% 187
2015
Q2
$7.99M Sell
68,200
-1,962
-3% -$230K 0.07% 137
2015
Q1
$6.89M Buy
70,162
+8,140
+13% +$799K 0.06% 156
2014
Q4
$5.85M Buy
62,022
+1,794
+3% +$169K 0.05% 170
2014
Q3
$6.41M Sell
60,228
-9,115
-13% -$970K 0.08% 147
2014
Q2
$5.75M Buy
69,343
+56,909
+458% +$4.72M 0.05% 158
2014
Q1
$881K Buy
12,434
+2,181
+21% +$155K 0.01% 633
2013
Q4
$770K Buy
10,253
+2,512
+32% +$189K 0.01% 434
2013
Q3
$487K Sell
7,741
-78,385
-91% -$4.93M 0.01% 404
2013
Q2
$4.42M Buy
+86,126
New +$4.42M 0.05% 160